Assignee
PROTHENA BIOSCIENCES LTD
IE·57 granted patents·51 pending applications·324 citations·filing 2013–2025
Top patents by PatentIndex Score
108 records- 0197US10961302B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Mar 30, 2021·7 cites·38 claims
- 0297US9884906B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Feb 6, 2018·12 cites·20 claims
- 0396US10752679B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Aug 25, 2020·11 cites·30 claims
- 0496US10633433B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Apr 28, 2020·9 cites·43 claims
- 0596US10501531B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 10, 2019·16 cites·26 claims
- 0696US10464999B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Nov 5, 2019·11 cites·78 claims
- 0796US10450369B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Oct 22, 2019·7 cites·43 claims
- 0896US9670273B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2015·Granted Jun 6, 2017·15 cites·21 claims
- 0995US10889638B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Jan 12, 2021·12 cites·196 claims
- 1095US10669330B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Jun 2, 2020·8 cites·32 claims
- 1195US10118960B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Nov 6, 2018·12 cites·22 claims
- 1295US9234031B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Jan 12, 2016·17 cites·9 claims
- 1395US9217030B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 22, 2015·17 cites·82 claims
- 1494US12195525B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2022·Granted Jan 14, 2025·1 cites·20 claims
- 1594US11028158B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jun 8, 2021·6 cites·36 claims
- 1694US10906967B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Feb 2, 2021·6 cites·30 claims
- 1794US10414825B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2016·Granted Sep 17, 2019·14 cites·25 claims
- 1894US9879080B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Jan 30, 2018·13 cites·36 claims
- 1993US12479910B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2024·Granted Nov 25, 2025·1 cites·21 claims
- 2093US10906964B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Feb 2, 2021·7 cites·65 claims
- 2193US10875909B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Dec 29, 2020·2 cites·17 claims
- 2293US10723792B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jul 28, 2020·3 cites·21 claims
- 2393US10407506B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2015·Granted Sep 10, 2019·13 cites·20 claims
- 2493US10081674B2Antibodies recognizing α-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Sep 25, 2018·18 cites·26 claims
- 2593US9605056B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2013·Granted Mar 28, 2017·22 cites·22 claims
- 2693US2025268999A1Treatment and Prophylaxis of AmyloidosisPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 2792US11492393B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Nov 8, 2022·2 cites·14 claims
- 2892US10494426B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Dec 3, 2019·9 cites·34 claims
- 2992US10301382B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2018·Granted May 28, 2019·10 cites·20 claims
- 3090US10875910B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Dec 29, 2020·2 cites·12 claims
- 3190US10597441B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Mar 24, 2020·4 cites·26 claims
- 3290US10584177B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2017·Granted Mar 10, 2020·6 cites·8 claims
- 3389US10669331B2Antibodies recognizing α-synucleinPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jun 2, 2020·3 cites·22 claims
- 3489US10407507B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2016·Granted Sep 10, 2019·6 cites·9 claims
- 3589US10059761B2Anti-Laminin4 antibodies specific for LG4-5PROTHENA BIOSCIENCES LTD·Filed 2015·Granted Aug 28, 2018·8 cites·37 claims
- 3688US11926659B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2021·Granted Mar 12, 2024·1 cites·32 claims
- 3786US11584791B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Feb 21, 2023·1 cites·17 claims
- 3885US11692024B2Methods of treating AL amyloidosisPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Jul 4, 2023·2 cites·42 claims
- 3985US10513555B2Antibody formulations and methodsPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 24, 2019·7 cites·23 claims
- 4084US12528858B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2022·Granted Jan 20, 2026·0 cites·7 claims
- 4181US12049498B2Humanized antibodies recognizing sortilinPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Jul 30, 2024·0 cites·10 claims
- 4280US12049497B2Antibodies recognizing sortilinPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Jul 30, 2024·0 cites·9 claims
- 4379US11267877B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Mar 8, 2022·1 cites·40 claims
- 4479US10654920B2Anti-laminin4 antibodies specific for LG4-5PROTHENA BIOSCIENCES LTD·Filed 2018·Granted May 19, 2020·1 cites·10 claims
- 4579US2024209073A1Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4678US11958896B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Apr 16, 2024·1 cites·22 claims
- 4778US2023340094A1Tau ImmunotherapyPROTHENA BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 4876US12240894B2Methods of treating AL amyloidosisPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Mar 4, 2025·0 cites·25 claims
- 4976US2023250161A1Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 5075US11345749B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted May 31, 2022·0 cites·5 claims
Showing the top 50 of 108 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →